Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2260482Generated: October 30, 2026

Thiosulfate ion → Bromide ion

https://huagongshe.com/reaction/2260482

Reaction equation

Participants

RoleNameHCIDCharge
ReactantThiosulfate ionHCID 1084—
Reactant2-(6-Hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acidHCID 3383—
ReactantTosylchloramideHCID 31388—
ReactantHomocysteineHCID 91552—
ReactantPotassium BromideHCID 253877—
SolventWaterHCID 962—
SolventSodium CarbonateHCID 10340—
SolventSodium HydroxideHCID 14798—
ProductBromide ionHCID 259—
ProductHomocysteineHCID 91552—

Reaction Steps

Hcy was further reacted with the BABA-activated BSA solutions prepared above. 20 mM 1-homocysteine was prepared by dissolving 1.5 mg of 1-homocysteine thiolactone in 0.5 ml 1M NaOH, incubating 10 minutes at 37° C. and finally diluting with 2.0 ml Na phosphate, pH 7.0, and 2.5 ml Na phosphate, pH 6.0 (final pH 7). Both BSA solutions prepared above were diluted to 4.0 ml with H2O and 1.0 ml of the Hcy solution was added to each and incubated overnight. The reactions were concentrated on a Centricon 30 and the reaction efficiency was estimated from the Br- concentration of the retained filtrates. Bromide standards were prepared by adding 2 μl of the appropriate KBr stock solutions to 98 μl of the -BABA-NHS reaction filtrate, producing standards with Br- concentrations of 0.0, 0.2, 0.4, 0.8, and 1.0 mM. 20 μl of the prepared Br- standards or 20 μl of the filtrate from the +BABA-NHS reaction were added to 0.9 ml of 0.1M Na citrate pH 5.5, followed by 20 μl of 0.8 mM fluorescein and 10 μl of 0.1M chloramine T. After 10 minutes, 20 μl of 25 mM thiosulfate in 0.2M Na2CO3 was added to stop the reaction and the absorbance recorded for each sample at 515 nm in a 1 cm cell. The absorbance values of the standards were plotted against the Br- concentrations to produce a standard curve, from which the concentration of Br- contained in the +BABA-NHS reaction was determined. From this value an estimate was obtained of the coupling efficiency of the BABA groups on BSA with Hcy. The +BABA-NHS reaction solution was concentrated 4 times on a Centricon 30, diluted with 1 ml 1×PBS (final conc. ~10 mg/ml) and set aside for subsequent antibody development.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05478729
Source datasetuspto-grants-1995_12
ORD IDord-bf7af0fc13474deebdb887e74628e098
Source noteuspto-grants-1995_12